Skip to main content
. 2017 Dec 1;8(69):113673–113686. doi: 10.18632/oncotarget.22817

Table 1. Clinical characteristics of the included MPM-patients (TCGA-set and LP-WGS-set).

Patient characteristics Absolute amount (percentage)
TCGA (N = 85) LP-WGS (N = 21)
Gender
 Male
 Female

69 (81%)
16 (19%)

19 (90%)
2 (10%)
Age at diagnosis
 Before or at the age of 60
 After the age of 60
 Unknown

32 (38%)
53 (62%)
0 (0%)

9 (43%)
10 (48%)
2 (10%)
History of asbestos exposure
 Yes
 No
 Unknown

54 (64%)
14 (16%)
17 (20%)

12 (57%)
0 (0%)
9 (43%)
Histologic diagnosis
 Epithelioid mesothelioma
 Non-epithelioid mesothelioma
 Unknown

56 (66%)
24 (28%)
5 (6%)

18 (86%)
3 (14%)
0 (0%)
Platinum/pemetrexed treatment prior to tissue collection
 No
 Yes

85 (100%)
0 (0%)

10 (48%)
11 (52%)
Time to death or last follow-up
 Less than 36 months
 More than 36 months
 Unknown

73 (86%)
11 (13%)
1 (1%)

16 (76%)
3 (14%)
2 (10%)
Vital status
 Dead
 Alive

56 (66%)
29 (34%)

15 (71%)
6 (29%)